Technology & AI

FDA and CMS work to avoid conflict over state AI rules

US health regulators are quietly acting to prevent clashes with states testing artificial intelligence in clinical care.

By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .

This story is no longer being updated. It reflects reporting up to .

What happened

The FDA and CMS are moving behind the scenes to head off a brewing conflict between states and the federal government over regulating AI. More states are looking to test AI in clinical settings. Health officials are seeking to prevent conflicts between state and federal authorities over AI systems that perform clinical tasks.

Coverage

More from Technology & AI

All Technology & AI news · Technology & AI story archive